Phio Pharmaceuticals Corp. (PHIO) › Net IncomePhio Pharmaceuticals Corp. (PHIO) — Net IncomeAnnual figures by fiscal year, from SEC filings.2003: -$89.0K2004: -$3.27M2005: -$2.21M2006: -$2.40M2007: -$10.99M2008: -$14.37M2009: -$18.39M2010: -$11.99M2011: -$2.54M2012: -$12.88M2013: -$20.93M2014: -$8.80M2015: -$10.22M2016: -$8.99M2017: -$12.45M2018: -$7.36M2019: -$8.91M2020: -$8.79M2021: -$13.29M2022: -$11.48M2023: -$10.83M2024: -$7.15M2025: -$8.70M-$8.70M2003Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$8.70M-21.7%2024-$7.15M+34.0%2023-$10.83M+5.7%2022-$11.48M+13.6%2021-$13.29M-51.1%2020-$8.79M+1.3%2019-$8.91M-21.0%2018-$7.36M+40.9%2017-$12.45M-38.4%2016-$8.99M+12.0%2015-$10.22M-16.2%2014-$8.80M+57.9%2013-$20.93M-62.5%2012-$12.88M-407.7%2011-$2.54M+78.8%2010-$11.99M+34.8%2009-$18.39M-27.9%2008-$14.37M-30.8%2007-$10.99M-357.0%2006-$2.40M-8.9%2005-$2.21M+32.5%2004-$3.27M-3576.4%2003-$89.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share